ACC Current Journal Review

Editorial board
pp. 4-4(1)

N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a global utilization of strategies to open occluded arteries (GUSTO)-IV substudy circulation
pp. 12-12(1)
Authors: James S.K.; Lindahl B.; Siegbahn A.

Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the assessment of the safety and efficacy of a new thrombolytic regimen (ASSENT) 3 plus randomized trial in acute myocardial infarction
pp. 12-12(1)
Authors: Wallentin L.; Goldstein P.; Armstrong P.W.

Comparison of clinical benefits of clopidogrel therapy in patients with acute coronary syndromes taking atorvastatin vs. other statin therapies
pp. 13-13(1)
Authors: Wienbergen H.; Gitt A.K.; Schiele R.; MITRA PLUS Study Group

Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis
pp. 13-13(1)
Authors: deFilippi C.; Wasserman S.; Rosanio S.

Waiting times, revascularization modality, and outcomes after acute myocardial infarction at hospitals with and without on site revascularization facilities in Canada
pp. 13-14(2)
Authors: Alter D.A.; Tu J.V.; Austin P.C.; Naylor C.D.

Regional variation in the treatment and outcomes of myocardial infarction: investigating New England's advantage
pp. 14-14(1)
Authors: Krumholz H.M.; Chen J.; Rathore S.S.; Wang Y.; Radford M.J.

Cardiovascular thrombotic events in arthritis trials of the cyclooxygenase-2 inhibitor celecoxib
pp. 14-15(2)
Authors: White W.B.; Faich G.; Borer J.S.; Makuch R.W.

Prognostic value of plasma von willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation
pp. 15-15(1)
Authors: Conway D.S.G.; Pearce L.A.; Chin B.S.P.; Hart R.G.; Lip G.Y.H.

Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease
pp. 15-15(1)
Authors: Topol E.J.; Easton D.; Harrington R.A.; Behalf of the Blockade of the Glycoprotein IIb/IIIa Receptor to Avoid Vascular Occlusion BRAVO Trial Investigators

Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism
pp. 16-16(1)
Authors: Kearon C.; Ginsberg J.S.; Kovacs M.J.; for the Extended Low-Intensity Anticoagulation for Thrombo-Embolism Investigators

Asymptomatic cardiac disease following mediastinal irradiation
pp. 16-16(1)
Authors: Heidenreich P.A.; Hancock S.L.; Lee B.K.; Mariscal C.S.; Schnitter I.

Heart disease and myocardial infarction in 1957: a patient's perspective
pp. 17-18(2)
Author: Armstrong W.F.

Prevalence of conventional risk factors in patients with coronary heart disease
pp. 23-23(1)
Authors: Khot U.N.; Khot M.B.; Bajzer C.T.

Major risk factors as antecedents of fatal and nonfatal coronary heart disease events
pp. 23-24(2)
Authors: Greenland P.; Knoll M.D.; Stamler J.

Estrogen plus progestin and the risk of coronary heart disease
pp. 24-24(1)
Authors: Manson J.E.; Hsia J.; Johnson K.C.; for the Women's Health Initiative Investigators

C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly
pp. 24-25(2)
Authors: Cao J.J.; Thach C.; Manolio T.A.

Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women
pp. 25-25(1)
Authors: Hodis H.N.; Mack W.J.; Azen S.P.; for the Women's Estrogen-Progestin Lipid-Lowering Hormone Atherosclerosis Regression Trial Rsearch Group

Effects of raloxifene on endothelial-dependent dilation, lipoproteins, and markers of vascular function in postmenopausal women with coronary artery disease
pp. 25-26(2)
Authors: Griffiths K.A.; Sader M.A.; Skilton M.R.; Harmer J.A.; Celermajer D.S.

Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the west of Scotland coronary prevention study
pp. 26-26(1)
Authors: Satar N.; Gaw A.; Scherbakova O.

Carotid intima-media thickness is associated with premature parental coronary heart disease
pp. 26-27(2)
Authors: Wang T.J.; Nam B.H.; D'Augustino R.B.

Guggulipid for the treatment of hypercholesterolemia. A randomized controlled trial
pp. 27-27(1)
Authors: Szapary P.O.; Wolfe M.L.; Bloedon L.T.

Recent advances in the diagnosis and treatment of pulmonary thromboembolism
pp. 28-32(5)
Authors: Kucher N.; Goldhaber S.Z.

Sustained cavity obliteration and apical aneurysm formation in apical hypertrophic cardiomyopathy
pp. 35-35(1)
Authors: Matsubara K.; Nakamura T.; Kuribayashi T.; Azuma A.; Nakagawa M.

Prognostic implications of intraventricular conduction defects in patients undergoing stress echocardiography for suspected coronary artery disease
pp. 35-35(1)
Authors: Cortigiani L.; Bigi R.; Gigli G.

Myocardial velocity gradient as a noninvasively determined index of left ventricular diastolic dysfunction in patients with hypertrophic cardiomyopathy
pp. 36-36(1)
Authors: Kato T.; Noda A.; Izawa H.

Silent and apparent cerebral embolism after retrograde catheterization of the aortic valve in valvular stenosis: a prospective, randomized study
pp. 36-36(1)
Authors: Omran H.; Schmidt H.; Hackenbroch M.; Illien S.

Low-gradient aortic stenosis: operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics
pp. 37-37(1)
Authors: Monin J.L.; Quere J.P.; Monchi M.

Detection of TIMI-3 flow before mechanical reperfusion with ultrasonic tissue characterization in patients with anterior wall acute myocardial infarction
pp. 37-37(1)
Authors: Iwakura K.; Ito H.; Kawano S.; Okamura A.

Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance
pp. 37-38(2)
Authors: McCrohon J.A.; Moon J.C.C.; Prasad S.K.

Preoperative thallium scanning, selective coronary revascularization and long-term survival after major vascular surgery
pp. 38-38(1)
Authors: Landesberg G.; Mosseri M.; Yehuda G.

Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS Trial): randomized controlled trial
pp. 42-42(1)
Authors: Cleland J.G.F.; Pennell D.J.; Ray S.G.; CHRISTMAS Carvedilol Hibernating Reversible Ischemia Trial Marker of Success Investigators

Combining low-intensity and maximal exercise test results improves prognostic prediction in chronic heart failure
pp. 42-42(1)
Authors: Rickli H.; Kiowski W.; Brehm M.

Antiremodeling effect of long-term exercise training in patients with stable chronic heart failure results of the exercise in left ventricular dysfunction and chronic heart failure (ELVD-CHF) trial
pp. 43-43(1)
Authors: Giannuzzi P.; Temporelli P.L.; Corra U.; Tavazzi T.; for the ELVD-CHF Study Group

Aspirin-angiotensin-converting enzyme inhibitor coadministration and mortality in patients with heart failure: a dose-related adverse effect of aspirin
pp. 43-43(1)
Authors: Guazzi M.; Brambilla R.; Reina G.; Tumminello G.; Guazzi M.

Use of rapamycin slows progression of cardiac transplantation vasculopathy
pp. 44-44(1)
Authors: Mancini D.; Pinney S.; Burkhoff D.

A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction
pp. 47-47(1)
Authors: Andersen H.R.; Nielsen T.T.; Rasmussen K.; for the DANAMI-2 Investigators

Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction
pp. 47-47(1)
Authors: Scheller B.; Hennen B.; Hammer B.; for the SIAM III Study Group

Randomized evaluation of polytetrafluoroethylene-covered stent in saphenous vein grafts: the randomized evaluation of polytetrafluoroethylene COVERed stent in saphenous vein grafts (RECOVERS) trial
pp. 47-48(2)
Authors: Stankovic G.; Colombo C.; Presbitero P.; for the RECOVERS Investigators

Coronary restenosis after sirolimus-eluting stent implantation: morphological description and mechanistic analysis from a consecutive series of cases
pp. 48-48(1)
Authors: Lemos P.A.; Saia F.; Ligthart J.M.R.

Effectiveness of sirolimus-eluting stent for treatment of left main coronary artery disease
pp. 48-49(2)
Authors: Arampatzis C.A.; Lemos P.A.; Tanabe K.

Predictors of subacute stent thrombosis: results of a systematic intravascular ultrasound study
pp. 49-49(1)
Authors: Cheneau E.; Leborgne L.; Mintz G.S.

C-reactive protein and coronary events following percutaneous coronary angioplasty
pp. 49-50(2)
Authors: de Winter R.J.; Koch K.T.; van Straalen J.P.

Usefulness of a cobalt chromium coronary stent alloy
pp. 50-50(1)
Authors: Kereiakes D.J.; Cox D.A.; Hermiller J.B.; for the Guidant Multi-Link Vision Stent Registry Investigators

Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts
pp. 50-50(1)
Authors: Stone G.W.; Rogers C.; Hermiller J.; for the FilterWire EX Randomized Evaluation FIRE Investigators

A new pacemaker algorithm for the treatment of atrial fibrillation. Results of the atrial dynamic overdrive pacing trial (ADOPT)
pp. 53-53(1)
Authors: Carlson M.D.; Ip J.; Messenger J.

Catheter ablation of paroxysmal atrial fibrillation initiated by non-pulmonary vein ectopy
pp. 53-53(1)
Authors: Lin W.S.; Tai C.T.; Hsieh M.H.

Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era
pp. 53-54(2)
Authors: Huikuri H.V.; Tapanainen J.M.; Lindgren K.

A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community. The Framingham Heart Study
pp. 54-54(1)
Authors: Wang T.J.; Massaro J.M.; Levy D.

A randomized comparison of atrial and dual-chamber pacing in 177 consecutive patients with sick sinus syndrome. Echocardographic and clinical outcome
pp. 54-54(1)
Authors: Nielsen J.C.; Kristensen L.; Andersen H.R.

Proarrhythmic effect of pacemaker stimulation in patients with implanted cardioverter-defibrillators
pp. 54-55(2)
Authors: Himmrich E.; Przibille O.; Zellerhoff C.

Racial differences in outcome in the multicenter unsustained tachycardia trial (MUSTT). A comparison of Whites vs. Blacks
pp. 55-55(1)
Authors: Russo A.M.; Hafley G.E.; Lee K.L.

T-wave alternans negative coronary patients with low ejection fraction and benefit from defibrillator implantation
pp. 55-55(1)
Authors: Hohnloser S.H.; Ikeda T.; Bloomfield D.M.; Dabbous O.H.; Cohen R.J.

A prospective randomized comparison of loop recorders vs. Holter monitors in patients with syncope or presyncope
pp. 55-56(2)
Authors: Sivakumaran S.; Krahn A.D.; Klein G.J.

Cost implications of testing strategy in patients with syncope. Randomized assessment of syncope trial
pp. 56-56(1)
Authors: Krahn A.D.; Klein G.J.; Yee R.; Hoch J.S.; Skanes A.C.

Nonsustained VT during exercise testing-causes and work-up
pp. 57-60(4)
Authors: Lin D.; Callans D.J.

Predictors of readmission for complications of coronary artery bypass graft surgery
pp. 62-62(1)
Authors: Hannan E.L.; Racz M.J.; Walford M.J.

Staphylococcus aureus bacteremia after median sternotomy: clinical utility of blood culture results in the identification of postoperative mediastinitis
pp. 62-62(1)
Authors: Fowler V.G.; Kaye K.S.; Simel D.L.

Clinical, angiographic, and interventional follow-up of patients with aortic-saphenous vein graft connectors
pp. 62-63(2)
Authors: Traverse J.H.; Mooney M.R.; Pedersen W.R.

Effect of body mass index on early outcomes in patients undergoing coronary artery bypass surgery
pp. 63-63(1)
Authors: Reeves B.C.; Ascione R.; Chamberlain M.H.; Angelini G.D.

Long-term follow-up of aortic intramural hematoma: predictors of outcome
pp. 63-64(2)
Authors: Evagelista A.; Dominguez R.; Sebastia C.

Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial
pp. 67-67(1)
Authors: McCrindle B.W.; Ose L.; Marais D.

Combined steroid treatment for congenital heart surgery improves oxygen delivery and reduces post bypass inflammatory mediator expression
pp. 67-67(1)
Authors: Schroeder V.A.; Pearl J.M.; Schwartz S.M.; Shanley T.P.; Manning P.B.; Nelson D.P.

Effect of two different bypass techniques on serum Troponin-T levels in newborns and children: does pH-Stat provide better protection?
pp. 67-68(2)
Authors: Nagy Z.L.; Collins M.; Sharpe T.

Differential regurgitation in branch pulmonary arteries after repair of tetralogy of fallot: a phase-contrast cine magnetic resonance study
pp. 68-68(1)
Authors: Kang I.S.; Redington A.N.; Benson L.N.

Recurrent pericarditis in children and adolescents: report of 15 cases
pp. 68-69(2)
Authors: Raatika M.; Pelkonen P.M.; Karjalainen J.; Jokinen E.J.

Neo-aortic root dilation and valve regurgitation up to 21 years after staged reconstruction for hypoplastic left heart syndrome
pp. 69-69(1)
Authors: Cohen M.S.; Marino B.S.; McElhinney D.B.

Length of stay after infant heart surgery is related to cognitive outcome at age 8 years
pp. 69-70(2)
Authors: Newburger J.W.; Wypij D.; Bellinger D.C.

Infants with complex congenital heart disease: the impact of fetal diagnosis
pp. 71-75(5)
Author: Gomez C.A.

Index
pp. 79-94(16)